Moderna
ValueWalk
Following is the unofficial transcript of a CNBC interview with Moderna Inc (NASDAQ:MRNA) CEO Stephane Bancel and CNBC “Squawk Box” Co-Anchor Joe Kernen live during the D50X Summit today, Thursday, October 20th. Interview With Moderna CEO Stephane Bancel JOE KERNEN: Hello, thank you. Disruptor of the decade at least, Stephane. And it is a household name. And it’s 50 billion now, but maybe a sore subject – but it shouldn’t be – it was 150 billion at the top. So, congratulations. Q3 2022 hedge fund letters, conferences and more Find A Qualified Financial AdvisorEach advisor has been vetted by Sm...
ValueWalk
Following is the unofficial transcript of a CNBC interview with Moderna Inc (NASDAQ:MRNA) CEO Stephane Bancel on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Thursday, March 24. Following is a link to video on CNBC.com: Moderna CEO Stephane Bancel On Fourth Covid Vaccine Dose, BA.2 Omicron VariantJOE KERNEN: Moderna holding its “Vaccine Day.” It’ll be announcing some new vaccine developments. Meg Tirrell joins us now with a special guest. Morning Meg. Q4 2021 hedge fund letters, conferences and more MEG TIRRELL: Good morning Joe. That special guest is Stéphane Bancel, the CEO of Moderna. Stéph...
ValueWalk
Pfizer Inc (NYSE:PFE) CEO Albert Bourla said “The two doses, they’re not enough for Omicron,” in reference to the efficacy of the company’s vaccine against COVID-19. He further added that the ability of the initial two-injection to prevent hospitalization dose has slightly waned. Q4 2021 hedge fund letters, conferences and more "Not Enough"As reported by CNBC, Pfizer CEO Albert Bourla said the two shots by the pharmaceutical giant are not enough to prevent Omicron. At a J.P. Morgan’s healthcare conference, he underlined the importance of a third dose to improve people’s chances against the var...
ValueWalk
Following is the unofficial transcript of a CNBC interview with Moderna Inc (NASDAQ:MRNA) CEO Stephane Bancel on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Monday, January 10. Following are links to video on CNBC.com: Q4 2021 hedge fund letters, conferences and more Moderna CEO Bancel: Future Covid Vaccine Booster Will Likely Target Omicron VariantModerna CEO: We Can Supply Up To 3 Billion Covid Vaccine Booster Doses This YearBECKY QUICK: The annual J.P. Morgan HealthCare Conference begins today. It’s the industry’s largest healthcare investments symposium and it will be virtual once again t...
ValueWalk
Vaccines currently trying to fight COVID-19 may not be as effective against the omicron variant, warned the CEO of Moderna Inc (NASDAQ:MRNA) Stephane Bancel. He stated it is unlikely that vaccines will be as efficient as they have been against previous strains, giving financial markets new reasons for concern about the future of the pandemic. Q3 2021 hedge fund letters, conferences and more Rising Concerns“There is no world, I think, where [the effectiveness] is the same level . . . we had with [the] Delta [variant],” said Bancel in an interview with the Financial Times, as he added: “I think ...
ValueWalk
Following is the unofficial transcript of a CNBC interview with Moderna Inc (NASDAQ:MRNA) CEO Stephane Bancel on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Monday, November 29. Following is a link to video on CNBC.com: Q3 2021 hedge fund letters, conferences and more Moderna CEO Stephane Bancel: Could Take Weeks For More Clarity On Omicron Covid VariantMEG TIRRELL: Hey Joe, Stephane Bancel joins us now. Stephane, thanks for being with us this morning. I think the whole world wants to hear from you and what you're doing on Omicron. But let's start first with the level of alarm or concern that...
ValueWalk
Following is the unofficial transcript of a CNBC interview with Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Wednesday, September 22. Following is a link to video on CNBC.com: Q2 2021 hedge fund letters, conferences and more Pfizer CEO On Providing 500 Million Vaccines To Low Income CountriesMEG TIRRELL: That special guest is Albert Bourla, the CEO of Pfizer. Albert, thanks for being with us this morning. Let's start with the news of the day, at least 500 million doses add to a previous agreement for the same number. They started shippin...
ValueWalk
Moderna Inc (NASDAQ:MRNA) recently announced to investors they are developing an experimental vaccine that will be optional to take, this vaccine will contain nicotine giving smokers a potent buzz. Moderna hopes this will boost jab rates amongst smokers, who are less likely to get vaccinated according to a recent Buzzfeed poll. Q2 2021 hedge fund letters, conferences and more Disclaimer: This is a satirical article. Moderna's New Vaccine Formula“We believe this optional vaccine will put us ahead of the bums over at Pfizer and at J&J.” Stephane Bancel, CEO of Moderna said. Conspiracy theorists ...
ValueWalk
Following is the unofficial transcript of a CNBC interview with Moderna Inc (NASDAQ:MRNA) CEO Stephane Bancel on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Thursday, August 5. Following is a link to video on CNBC.com: Q2 2021 hedge fund letters, conferences and more Moderna CEO On Its Latest Vaccine Efficacy DataMEG TIRRELL: Stephane Bancel, the CEO of Moderna joins us now. Stephane, welcome. You’ve got a lot of news in your release this morning in addition to your earnings, particularly about your COVID vaccine. Let’s start with the six-month results that you have showing 93% efficacy is du...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら